Second quarter results 2010
(Thomson Reuters ONE) -
Navamedic ASA Interim Financial report for Q 2 2010.
* Improved profitability in Vitaflo Scandinavia, following improved Gross
Margin and reduced operating costs
* Registration of the Aspen portfolio progressing according to plan. Product
launches expected from 2H 2011
* Increased cooperation with Aspen with Navamedic taking over sales and
marketing responsibility for 8 products from September 1.
* New experienced CFO commence duty on September 1st 2010, further
strengthening Navamedic in its aim to remain a Nordic specialty pharma
company.
For further information, please contact:
Olof Milveden, CEO Navamedic ASA
E-mail:olof.milveden(at)navamedic.com
Office: +46 31 335 11 90
Mobile: +46 733 46 37 36
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1440369]
Navamedic ASA Q2 2010 presentation:
http://hugin.info/136020/R/1440369/384770.ppt
Navamedic ASA Q2 2010 report:
http://hugin.info/136020/R/1440369/384769.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Navamedic ASA via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 26.08.2010 - 06:30 Uhr
Sprache: Deutsch
News-ID 40042
Anzahl Zeichen: 0
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Second quarter results 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Navamedic ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
